Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial (Q44412916)
scientific article published on April 23, 2003
Language:
(P31) (Q13442814)
(P50) (Q60902988)
(Q56689362)
(P304) 2073-2082
(P407) (Q1860)
(P433) 16
(P478) 289
(P577) Tuesday, April 1, 2003
Wednesday, April 23, 2003
(P921) (Q11068)
(Q410291)
(P953) https://jamanetwork.com/journals/jama/articlepdf/1357322/joc21571.pdf
http://jamanetwork.com/journals/jama/fullarticle/1357322
(P1433) (Q1470970)
(P1476) "Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial" (language: en)
"Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial" (language: en)
(P2093) Gregory Grandits
Patricia Grambsch
Tracy Lucente
Lennart Hansson
Yves Lacourciere
James Muller
Peter Sleight
Gordon Williams
CONVINCE Research Group
Henry R. Black
William J. Elliott
William B. White
James D. Neaton
Richard H. Grimm
Michael A. Weber
Robert J. Anders
other details
description scientific article published on April 23, 2003

External Links